Compare TEO & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEO | MMED |
|---|---|---|
| Founded | 1979 | 1983 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.1B |
| IPO Year | 1997 | 2025 |
| Metric | TEO | MMED |
|---|---|---|
| Price | $10.51 | $18.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 16 |
| Target Price | $17.12 | ★ $25.47 |
| AVG Volume (30 Days) | 326.5K | ★ 15.5M |
| Earning Date | 11-17-2026 | 11-13-2026 |
| Dividend Yield | ★ 2.54% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $3,102,000,000.00 |
| Revenue This Year | $16.64 | $10.76 |
| Revenue Next Year | $1.24 | $8.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 14.25 |
| 52 Week Low | $10.35 | $10.65 |
| 52 Week High | $16.34 | $24.43 |
| Indicator | TEO | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 28.79 | 48.76 |
| Support Level | N/A | $16.55 |
| Resistance Level | $12.45 | $20.88 |
| Average True Range (ATR) | 0.66 | 0.80 |
| MACD | -0.19 | 0.16 |
| Stochastic Oscillator | 4.32 | 75.42 |
Telecom Argentina SA offers its customers quadruple play services, combining mobile telephony services, cable television services, Internet services and fixed telephony services. It also provides other telephone-related services such as international long-distance and wholesale services, data transmission and IT solutions outsourcing and install, operate and develop cable television and data transmission services. The company operates in segments: ICT Services provided in Argentina: Personal Network; ICT Services provided in Argentina - TMA Network; and Other segments..
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.